Synthesis and biological evaluation of certain 2H-pyran-2-ones and some derived 1H-pyridin-2-one analogs as antimicrobial agents

Saudi Pharmaceutical Journal

Volumn 16, Issue 1, 2008, Pages 33-42

  Faidallah, Hassan M ^a   Al Saadi, Mohammed S ^a   Rostom, Sherif A F ^a  

^a Aziz University   (Saudi Arabia)

Author keywords

Antibacterials; Antifungals; Antimycobacterials; Pyran 2 ones; Pyridin 2 ones

Indexed keywords

1 AMINO 4 (4 NITROPHENYL) 5,6 DIPHENYL 1H PYRIDIN 2 ONE; 1 HYDROXY 4 (4 NITROPHENYL) 5,6 DIPHENYL 1H PYRIDIN 2 ONE; 1 METHYL 4 (4 NITROPHENYL) 5,6 DIPHENYL 1H PYRIDIN 2 THIONE; 3 (4 NITROPHENYL) 4,5 DIPHENYL 5 OXOPENT 3 ENOIC ACID; 3 BROMO 4 (4 NITROPHENYL) 5,6 DIPHENYL 2H PYRAN 2 ONE; 3 NITRO 4 (4 NITROPHENYL) 5,6 DIPHENYL 2H PYRAN 2 ONE; 4 (4 NITROPHENYL) 5,6 DIPHENYL 1H PYRIDIN 2 ONE; 4 (4 NITROPHENYL) 5,6 DIPHENYL 2H PYRAN 2 ONE; 4 (4 NITROPHENYL) 5,6 DIPHENYL 2H PYRAN 2 ONE OXIME; 4 (4 NITROPHENYL) 5,6 DIPHENYL 2H PYRAN 2 ONE PHENYLHYDRAZONE; 4 (4 NITROPHENYL) 5,6 DIPHENYL 2H PYRAN 2 THIONE; ANTIINFECTIVE AGENT; COTRIMOXAZOLE; PYRAN DERIVATIVE; PYRIDONE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; BACTERIAL GROWTH; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; ESCHERICHIA COLI; GROWTH INHIBITION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PSEUDOMONAS AERUGINOSA; REACTION ANALYSIS; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION;

EID: 39749127954     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Dickinson J M. Microbial Pyran-2-ones and Dihydropyran-2-ones. Nat Prod Rep 1993; 10: 71-98.
2. Douglas C J, Sklenika H M, Shen H C, Mathias D S, Degen S J, Golding G M, Morgan C D, Shin R A, Mueller K L, Scurer L M, Johnson E W, Hsung R P. Synthesis and UV Studies of a Small Library of 6-Aryl-4-hydroxy-2-pyrones. A Relevant Structural Feature For the Inhibitory of Arisugacin Against Acetyl Choline Esterase. Tetrahedron 1999; 55: 13683-96.
3. Hatch M S, Brown W M, Deck J A, Hunsaker L A, Deck L M, Vander Jagt D L. Inhibition of Yeast Lipase (CRL1) and Cholesterol Esterase (CRL3) by 6-Chloro-2-pyrones: Comparison With Porcine Cholesterol Esterase. Biochemica et Biophysica Acta-Protein Structure and Molecular Enzymology 2002; 1596: 381-91.
4. Tuchinda P, Reutrakul V, Claeson P, Pongprayoon U, Sematong T, Santisuk T, Taylor W C. Anti-inflammatory Cyclohexenylchalcone derivatives in Boesenbergia pandurata. Phytochemistry 2002; 59: 169-73.
5. Rao P N P, Uddin J, Knaus E E. Design, Synthesis, and Structure-Activity Relationship Studies of 3,4,6-Triphenylpyran-2-ones as Selective Cyclooxygenase-2 Inhibitors. J Med Chem 2004; 47: 3972-90.
6. Fujimoto H, Okamoto Y, Sone E, Maeda S, Akiyama K, Ishibashi M. Eleven New 2-Pyrones from a Fungi Imperfecti, Trichurus terrophilus, Found in a Screening Study Guided by Immunomodulatory Activity. Chem Pharm Bull 2005; 53: 923-29.
7. Marrison L R, Dickinson J M, Fairlamb I J S. Bioactive 4-Substituted-6-methyl-2-pyrones with Promising Cytotoxicity against A2780 and K562 Cell Lines. Bioorg Med Chem Lett 2002; 12: 3509-15.
8. Marrison L R, Dickinson J M, Fairlamb I J S. Suzuki Cross-Coupling Approaches to the Synthesis of Bioactive 3-Substituted and 5-Substituted-4- methoxy-6-methyl-2-pyrones. Bioorg Med Chem Lett 2003; 13; 2667-71.
9. De Clercq E. Toward Improved Anti-HIV Chemotherapy: Therapeutic Strategies For Intervention With HIV Infections. J Med Chem 1995; 38: 2491-517.
10. De Clercq E. New Developments in Anti-HIV Chemotherapy. Biochemica et Biophysica Acta - Molecular Basis of Disease 2002; 1587: 258-75.
11. Fairlamb I J S, Marrison L R, Dickinson J M, Lu F-J, Schmidt J P. 2-Pyrones Possessing Antimicrobial and Cytotoxic activities. Bioorg Med Chem 2004; 12; 4285-4299.
12. McGlacken G P, Fairlamb I J S. 2-Pyrone Natural Products and Mimetics: Isolation, Charactarization and Biological Activity. Nat Prod Rep 2005; 22: 369-85.
13. Fossa P, Menozzi G, Dorigo P, Floreani M, Mosti L. Synthesis and Pharmacological Characterization of Functionalized 2-Pyridones Structurally Related to the Cardiotonic Agent Milrinone. Bioorg Med Chem 2003;11: 4749-59.
14. Krauze A, Vitolina R, Garaliene V, Sile L, Kluša V, Duburs G. 3,4-trans-4-Aryl-3-(1-pyridinio) -1 ,2 ,3 ,4-tetrahydropyridine-6- thiolates. New Group of Potential Cardiotonic Drugs. Eur J Med Chem 2005; 40: 1163-67.
15. Ochoa E, Suarez M, Verdecia Y, Pita B, Martin N, Quinteiro M, Seoane C, Soto J L, Duque J, Pomes R. Structural Study of 3,4-Dihydropyridones and Furo[3,4-b]-2(1H)-pyridones as Potential Calcium Channel Modulators. Tetrahedron 1998; 54; 12409-20.
16. Parlow J J, South M S. Synthesis of 2-pyridones as Tissue Factor VIIa Inhibitors.Tetrahedron 2003; 59: 7695-7701.
17. Klimesova V, Svoboda M, Waisser K, Pour M, Kaustova J. New Pyridine Derivatives as Potential Antimicrobial Agents. Il Farmaco 1999; 54: 666-72.
18. Abdel-Aziz A A, El-Subbagh H I, Kunieda T. Lewis Acid-Promoted Transformation of 2-Alkoxypyridines Into 2-Aminopyridines and Their Antibacterial Activity. Part 2: Remarkably Facile C-N Bond Formation. Bioorg Med Chem 2005;13: 4929-35.
19. Perez-Rebolledo A, Ayala J D, de Lima G M, Marchini N, Bombieri G, Zani C L, Souza-Fagundes E M, Beraldo H. Structural Studies and Cytotoxic Activity of N(4)-phenyl-2-benzoylpyridine thiosemicarbazone Sn(IV) Complexes. Eur J Med Chem 2005; 40: 467-72.
20. Cocco M T, Congiu C, Lilliu V, Onnis V. Synthesis and Antiproliferative Activity of 2,6-Dibenzylamino-3,5-dicyanopyridines on Human Cancer Cell Lines. Eur J Med Chem. 2005; 40: 1365-72.
21. Mamolo M G, Falagiani V, Vio L, Banfi E. Synthesis and Antimycobacterial Activity of Some N1-[1-[3-aryl-1-(pyridine-2-, 3-, 4-yl) - 3- oxo] propyl] -2- pyridinecarboxamidrazones. Il Farmaco 1999; 54: 761-67.
22. Ranft D, Seyfarth T, Schaper K-J, Lehwark-Yvetot G, Bruhn C, Buege A. New N1-Hetarylmethylene-Substituted Amidrazones With Potential Antimycobacterial Activity. Arch. Pharm. Pharm. Med. Chem. 1999; 332: 427-30.
23. Barrel K, Balzarini J, Neyts J, De Clercq E, Hider R C, Camplo M. Synthesis and Antiviral Evaluation of Cyclic and acyclic 2-Methyl-3-hydroxy-2- pyridinone Nucleoside Derivatives. J Med Chem 2006; 49: 43-50.
24. Hardman J G, Limbird L E, Gilman A G, editors. Bennet J E In: Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th ed. McGraw-Hill, Medical Publishing Division, New York, 2001:1309.
25. Williams D A, Lemke T L, Foye's Principles of Medicinal Chemistry. 5th ed., Lippincot Williams and Wilkins, Philadelphia, USA, 2002: a: 906; b: 871.
26. st ed., Lea and Febiger, USA, 1988: 135-38.
27. Mamolo M G, Vio L. Synthesis and Antimycobacterial Activity of Some 2-Pyridinecarbox-amidrazone Derivatives. Il Farmaco 1992; 47: 1055-1066.
28. Lokot I P, Pashkovsky F S, Lakhvieh F A. A New Approach to the Synthesis of 3,6- and 5,6-Dialkyl Derivatives of 4-Hydroxy-2-pyrone. Synthesis of rac-Germicidin. Tetrahedron 1999; 55: 4783-92.
29. Liu K, Xu L. Synthesis of 5,6-Dihydro-4-hydroxy-2-pyrones via Formal Cycloaddition Reactions. Tetrahedron Letters 2000; 41: 3299-302.
30. Hachiya I, Shibuya H, Shimizu M. Novel 2-Pyrone Synthesis via the Nucleophilic Addition of Active Methine Compounds to 2-Alkynone. Tetrahedron Letters 2003; 44: 2061-63.
31. Walker G N. Michel Addition Products From (2,3-Dimethoxyphenyl)propiolic acid Derivatives. J. Am. Chem. Soc. 1954; 76: 309-10.